TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA BONE GLUE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 CURRENCY AND PRICING
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELLING
2.6 PRODUCTS LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 RESTRAINT
5.1.1 STRINGENT REGULATORY SCENARIO
5.2 OPPORTUNITIES
5.2.1 INCREASING PREVALENCE OF OSTEOPOROSIS
5.2.2 INCREASING RESEARCH ACTIVITIES FOR BONE GLUE
5.2.3 UNMET MEDICAL NEEDS IN OSTEOPOROSIS MANAGEMENT
5.2.4 INCREASING HEALTHCARE EXPENDITURE IN ORTHOPEDIC
5.2.5 RISING CASES OF MULTIPLE FRACTURE INJURIES AND OTHER BONE RELATED DISORDERS
5.2.6 COMPETITIVE ADVANTAGES
5.3 CHALLENGE
5.3.1 AVAILABILITY OF OTHER ALTERNATIVES
6 MIDDLE EAST AND AFRICA BONE GLUE MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 VERTEBROPLASTY
6.3 ARTHROPLASTY
6.4 ORTHOPAEDICS
6.5 SPORTS INJURIES
6.6 MAXILLOFACIAL SURGERY
6.7 TRAUMA
6.8 OTHERS
7 MIDDLE EAST AND AFRICA BONE GLUE MARKET, BY END-USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 AMBULATORY SURGICAL CENTERS
7.4 SPECIALIZED ORTHOPEDICS CLINICS
8 MIDDLE EAST AND AFRICA BONE GLUE MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT SALES
8.3 RETAIL SALES
9 MIDDLE EAST AND AFRICA BONE GLUE MARKET, BY GEOGRAPHY
9.1 MIDDLE EAST AND AFRICA
10 COMPANY PROFILE
10.1 LAUNCHPAD MEDICAL
10.1.1 COMPANY SNAPSHOT
10.1.2 CLINICAL TRIAL
10.1.3 PRODUCT PORTFOLIO
10.1.4 RECENT DEVELOPMENTS
11 QUESTIONNAIRE
12 RELATED REPORTS